M. Lipka

Retinoblastoma mutation predicts poor outcomes in advanced non small cell lung cancer

N. Sharma, M. Chiu, G. Wildey, 2019, Cancer medicine.

A detailed smoking history and determination of MYC status predict response to checkpoint inhibitors in advanced non-small cell lung cancer

M. Chiu, P. Fu, A. Dowlati, 2020, Translational lung cancer research.

KMT2D Mutation Is Associated With Poor Prognosis in Non–Small‐Cell Lung Cancer

N. Sharma, P. Fu, A. Dowlati, 2018, Clinical lung cancer.

Next Generation Sequencing of Advanced Non-Small Cell Lung Cancer: Utilization Based on Race and Impact on Survival.

P. Fu, A. Dowlati, S. Cao, 2020, Clinical lung cancer.

Clinical correlation of extensive-stage small-cell lung cancer genomics.

G. Wildey, P. Fu, A. Dowlati, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Reciprocal expression of INSM1 and YAP1 defines subgroups in small cell lung cancer

V. Velcheti, G. Wildey, P. Fu, 2017, Oncotarget.

Reciprocal expression of INSM1 and YAP1 defines subgroups in small cell lung cancer

V. Velcheti, G. Wildey, P. Fu, 2017, Oncotarget.

MA14.01 Updated Dataset Assessing Tumor Mutation Burden (TMB) as a Biomarker for Response to PD-1/PD-L1 Targeted Therapies in Lung Cancer (LC)

James X. Sun, P. Stephens, S. Ou, 2017 .